ARCHIVES

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

Advances In Cancer Control Meeting Is Set For March 22

February 3, 1989

Mammography For Women Under 50 Debated; Cut Of 3-4% Offered As Budget Trimmer

July 23, 1976

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

February 15, 2002

FDA carries Action On Two Cancer Drugs Over To 1996

January 5, 1996

ASCO Letter To NCI Urges Increased Support for Clinical Trials, Training, Translational Research

March 6, 2009

Obama Executive Order Gives FDA Authority To Combat Drug Shortages

November 4, 2011